Results 1 to 10 of about 36,054 (205)

Effectiveness of Prophylactic Human Papillomavirus Vaccine in the Prevention of Recurrence in Women Conized for HSIL/CIN 2-3: The VENUS Study

, 2022
Background: Recent data have shown that the human papillomavirus (HPV) vaccine could impact on a decrease in high-grade cervical intraepithelial lesions (HSIL) in women who have undergone surgical treatment.
Casajuana-Perez, Andrea, Estefanía Ruipérez-Pacheco, de la Fuente-valero, Jesus, Hernandez-Aguado, Juan J., Andrea Casajuana-Pérez, Ramirez-Mena, Mar, Ruiperez-Pacheco, Estefania, Javier García-Santos, Juan J. Hernández-Aguado, Zapardiel, Ignacio, Gil-Prados, Ines, Bellon-del Amo, Monica, Coronado-Martin, Pluvio J., Ignacio Zapardiel, Pluvio J. Coronado-Martín, Mónica Bellón-del Amo, Garcia-Santos, Javier, Inés Gil-Prados, Mar Ramírez-Mena, Jesus de la Fuente-Valero   +19 more
core   +1 more source

Awareness, Acceptance, and Associated Factors of Human Papillomavirus Vaccine among Parents of Daughters in Hadiya Zone, Southern Ethiopia: A Cross-Sectional Study

, 2022
Introduction: Human papillomavirus infections are the most prevalent sexually transmitted disease among women worldwide. Cervical cancer is the second-most frequent disease worldwide in terms of incidence and mortality, and it is primarily responsible ...
Elilo, Legesse Tesfaye, Legesse Tesfaye Elilo, Larebo, Yilma Markos, Akiso, Denebo Ersulo, Anshebo, Abebe Alemu, Gopalan, Natarajan, Abebe Alemu Anshebo, Abame, Desta Erkalo, Bawore, Solomon Gebre, Desta Erkalo Abame, Yilma Markos Larebo, Solomon Gebre Bawore, Natarajan Gopalan, Denebo Ersulo Akiso   +13 more
core   +1 more source

Intra-epithelial vaccination with COPV L1 DNA by particle-mediated DNA delivery protects against mucosal challenge with infectious COPV in beagle dogs.

, 2001
Protection against viral challenge with canine oral papillomavirus (COPV) was achieved by immunisation via particle-mediated DNA delivery (PMDD) of a plasmid encoding the COPV L1 gene to cutaneous and oral mucosal sites in beagle dogs.
Walcott, S., Nicholls, P.K., Thomsen, L., Stanley, M.A., Santos, E.B., Moore, R.A., Parry, N., Gough, G.   +7 more
core  

Canine papillomavirus-A Centenary review

, 1999
One hundred years have passed since the first reports of transmissible warts in the dog were noted in this journal by its founder (M'Fadyean and Hobday, 1898; Penberthy, 1898). These early observations by M'Fadyean, Penberthy and Hobday started a line of
Nicholls, P.K., Stanley, M.A.
core  

A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania [PDF]

, 2012
Background As human papillomavirus (HPV) vaccines become available in developing countries, acceptability studies can help to better understand potential barriers and facilitators of HPV vaccination and guide immunisation programs. Methods Prior
Hayes, R.J., de Sanjosé, Silvia, Kapiga, Saidi, Changalucha, John, Ross, David A., Hayes, Richard J., Watson-Jones, Deborah, Kapiga, S., Remes, Pieter, Watson-Jones, D., Wight, D., Changalucha, J., Selestine, Veronica, Hayes, Richard J, Selestine, V., de Sanjosé, S., Ross, D.A., Remes, P., Ross, David A, Wight, Daniel   +19 more
core   +1 more source

Comparison of the Immune Responses to Different Formulations of BC02-Adjuvanted HPV Types 16 and 18 Bivalent Vaccines in Mice

, 2023
To achieve maximum efficacy, vaccines, such as subunit, recombinant, and conjugate vaccines, necessitate the incorporation of immunostimulators/adjuvants.
Xiaonan Guo, Guozhi Wang, Jiaxin Dong, Miao Xu, Huicong Xie, Junli Li, Lili Fu, Aihua Zhao   +7 more
core   +1 more source

Advancing the Fight Against Cervical Cancer: The Promise of Therapeutic HPV Vaccines

Human papillomavirus (HPV) is a major global health issue and is recognized as the leading cause of cervical cancer. While prophylactic vaccination programs have led to substantial reductions in both HPV infection rates and cervical cancer incidence ...
Ling Long, Dongling Zou, Xiuying Li, Yue Huang, Qian Zheng, Misi He, Mingfang Guo, Zejia Mao   +7 more
core   +1 more source

The Clinical Effectiveness of Single-Dose Human Papillomavirus Vaccination

The human papillomavirus (HPV) vaccine was initially approved for a three-dose regimen. Due to resource limitations, budget constraints, low acceptance, and poor adherence, global vaccination coverage is only 15%.
Zhengyu Li, Yue Huang, Rongyu Liu, Wanying Bao, Xinlin He   +4 more
core   +1 more source

Knowledge of human papillomavirus vaccines among university students in Angola

, 2022
Introduction: Cervical cancer is the first most common cancer among women in Angola and accounts for 37.6% of cancers among women in Angola. The human papillomavirus (HPV) is a causative agent of the disease. Recent advances in technology have led to the
Ana Morais Vasconcelos, Honolfo Elves Simões, Nilton Helibrando Rosa, Elizandra Soqui, João Wilson Rocha   +4 more
core   +1 more source

School nurses' experiences of delivering the UK HPV vaccination programme in its first year [PDF]

, 2011
Background: In the United Kingdom (UK) in September 2008, school nurses began delivering the HPV immunisation programme for girls aged 12 and 13 years old. This study offers insights from school nurses' perspectives and experiences of delivering this new
Hilton, S., Hunt, Kate, Petticrew, Mark, Bedford, H., Mark Petticrew, Hunt, K., Bedford, Helen, Hilton, Shona, Shona Hilton, Kate Hunt, Helen Bedford, Petticrew, M.   +11 more
core   +1 more source